Afatinib in Advanced Refractory Urothelial Cancer
Stopped Unable to meet accrual goal after several years
Conditions
- Distal Urethral Cancer
- Proximal Urethral Cancer
- Recurrent Bladder Cancer
- Recurrent Urethral Cancer
- Stage III Bladder Cancer
- Stage III Urethral Cancer
- Stage IV Bladder Cancer
- Stage IV Urethral Cancer
- Ureter Cancer
Interventions
- DRUG: afatinib dimaleate
- OTHER: laboratory biomarker analysis
Sponsor
University of Chicago
Collaborators